Mount Pleasant Ventures logo

Mount Pleasant Ventures

North America, District of Columbia, United States, Washington

Description

Mount Pleasant Ventures provides angel investment to early-stage organizations.

Investor Profile

Mount Pleasant Ventures has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mount Pleasant Ventures frequently co-invest with?

First Round Capital
North America, California, United States, San Francisco
Co-Investments: 1
Builders VC
North America, California, United States, San Francisco
Co-Investments: 1
HM
North America, California, United States, Palo Alto
Co-Investments: 1
ZAKA VC
Europe, Hlavni mesto Praha, Czech Republic, Prague
Co-Investments: 1
Bioverge
North America, California, United States, San Francisco
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
SNR.vc
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Mount Pleasant Ventures often collaborate with?

KM
North America, California, United States, San Francisco
Shared Deals: 1
VR
North America, California, United States, San Francisco
Shared Deals: 1
MA
North America, California, United States, San Francisco
Shared Deals: 1
MD
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Mount Pleasant Ventures?

Eigen Therapeutics

Redwood City, California, United States

Biotechnology company developing combination therapeutics for cancer

BiotechnologyLife Science
SeedDec 8, 2022
Amount Raised: $7,000,000